High-Density Lipoproteins :Structure, Metabolism, Function and Therapeutics

Publication subTitle :Structure, Metabolism, Function and Therapeutics

Author: Anatol Kontush  

Publisher: John Wiley & Sons Inc‎

Publication year: 2011

E-ISBN: 9781118158647

P-ISBN(Hardback):  9780470408216

Subject: Q513 binding protein

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Description

A complete guide to the role of high-density lipoproteins (HDL) in new and emerging therapies

With high-density lipoproteins (HDL) playing an increasing role in cardiovascular disease prevention, there is a growing need for an in-depth look at HDL and its clinical value. This book summarizes the current state of knowledge in the field, providing for the first time a comprehensive, systematic, stylistically coherent, and up-to-date review of the composition, structure, heterogeneity, metabolism, epidemiology, genetics, and function of HDL.

Divided into three main parts, High-Density Lipoproteins first examines normal HDL particles, then describes defective HDL, and finally addresses the therapeutic normalization of subnormal levels and defective biological activities of this lipoprotein class. The book highlights the functional properties of HDL, which are relevant to the pathophysiology of atherosclerosis and thrombosis, and discusses the compositional and metabolic heterogeneity of HDL particles.

Readers will come away with a clear understanding of the role of HDL in biological processes, the potential value of functional HDL as a therapeutic target, and how current and emerging therapies are poised to influence the treatment of heart disease in the future.

Chapter

CONTENTS

pp.:  9 – 17

PREFACE

pp.:  17 – 33

ACKNOWLEDGMENTS

pp.:  33 – 35

ABBREVIATIONS

pp.:  35 – 39

SECTION 1 NORMAL FUNCTIONAL HIGH-DENSITY LIPOPROTEIN

pp.:  39 – 343

SECTION 2 FUNCTIONALLY DEFECTIVE HDL

pp.:  343 – 455

SECTION 3 THERAPEUTIC NORMALIZATION OF SUBNORMAL LEVELS AND DEFECTIVE BIOLOGIC ACTIVITIES OF HDL

pp.:  455 – 610

CONCLUSIONS AND PERSPECTIVES

pp.:  610 – 615

INDEX

pp.:  615 – 650

The users who browse this book also browse